The Mechanism and Potential Therapeutic Effects of Cyclosporin, Cyclophilin, Probiotics and Syndecan-1 in an Animal Model of Inflammatory Bowel Disease

• Prif Awduron: Laura Dosh (Awdur), Francesca Rappa (Awdur), Abdo Jurjus (Awdur), Gaelle Karam (Awdur), Roaa Lezeik (Awdur), Jad El Masri (Awdur), Fabio Bucchieri (Awdur), Angelo Leone (Awdur), Rosalyn Jurjus (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2024-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

<b>Background:</b> Inflammatory bowel diseases (IBDs) have several treatment modalities including immunoregulators, like cyclosporine A, an immunosuppressant that interacts with cytoplasmic cyclophilin A, and probiotics. <b>Aims:</b> This study explored and compared the possi...